References
- JinMYangFYangIUric acid, hyperuricemia and vascular diseasesFront Biosci (Landmark Ed)201217165666922201767
- BakerJFSchumacherHRUpdate on gout and hyperuricemiaInt J Clin Pract201064337137719909378
- TerkeltaubRUpdate on gout: new therapeutic strategies and optionsNat Rev Rheumatol201061303820046204
- KapoorRKakkarPProtective role of morin, a flavonoid, against high glucose induced oxidative stress mediated apoptosis in primary rat hepatocytesPLoS One20127841663
- SubashSSubramanianPMorin a flavonoid exerts antioxidant potential in chronic hyperammonemic rats: a biochemical and histopathological studyMol Cell Biochem20093271–215316119238524
- CaselliACirriPSantiAPaoliPMorin: a promising natural drugCurr Med Chem201623877479126018232
- YuZFongWPChengCHThe dual actions of morin (3,5,7,2′,4′-pentahydroxyflavone) as a hypouricemic agent: uricosuric effect and xanthine oxidase inhibitory activityJ Pharmacol Exp Ther2006316116917516169936
- SinhaKGhoshJSilPCMorin and its role in chronic diseasesAdv Exp Med Biol201692845347127671828
- ZhangJJShuaiXLiJBXiangNXGongTZhangZRBiodistribution, hypouricemic efficacy and therapeutic mechanism of morin phospholipid complex loaded self-nanoemulsifying drug delivery systems in an experimental hyperuricemic model in ratsJ Pharm Pharmacol2016681142526806696
- ZhangJPengQShiSPreparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complexInt J Nanomedicine201163405341422267925
- WaddadAYAbbadSYuFFormulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactantsInt J Pharm2013456244645823998955
- BesheerAHauseGKresslerJMaderKHydrophobically modified hydroxyethyl starch: synthesis, characterization, and aqueous self-assembly into nano-sized polymeric micelles and vesiclesBiomacromolecules20078235936717256901
- LiGLiYTangYHydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydroxy camptothecinInt J Pharm20144711–223424424861941
- GoszczyńskiTMFilip-PsurskaBKempińskaKWietrzykJBoratyńskiJHydroxyethyl starch as an effective methotrexate carrier in anticancer therapyPharmacol Res Perspect201423e0004725505592
- YangJGaoCLüSZhangXYuCLiuMPhysicochemical characterization of amphiphilic nanoparticles based on the novel starch-deoxycholic acid conjugates and self-aggregatesCarbohydr Polym201410283884524507354
- ZhangJLiJJuYFuYGongTZhangZMechanism of enhanced oral absorption of morin by phospholipid complex based self-nanoemulsifying drug delivery systemMol Pharm201512250451325536306
- BesheerAVogelJGlanzDKresslerJGrothTMaderKCharacterization of PLGA nanospheres stabilized with amphiphilic polymers: hydrophobically modified hydroxyethyl starch vs pluronicsMol Pharm20096240741519718794
- PaleosCMSideratouZTsiourvasDDrug delivery systems based on hydroxyethyl starchBioconjugate Chemistry20172861611162428431209
- LiJHuoMWangJRedox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxelBiomaterials20123372310232022166223
- ShapiroNITrzeciakSHollanderJEThe diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsisAnn Emerg Med2010561525920363526
- ElhmidiYBleizifferSPiazzaNIncidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantationAm Heart J2011161473573921473973
- ChoiKYChungHMinKHSelf-assembled hyaluronic acid nanoparticles for active tumor targetingBiomaterials201031110611419783037
- BaierGBaumannDSiebertJMMusyanovychAMailanderVLandfesterKSuppressing unspecific cell uptake for targeted delivery using hydroxyethyl starch nanocapsulesBiomacromolecules20121392704271522844871
- LapsiaVJohnsonRJDassBElevated uric acid increases the risk for acute kidney injuryAm J Med20121253e9e17